Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 542,000 | 432,000 | 778,000 | 447,000 | 640,000 |
| Receivables | 384,000 | 427,000 | 386,000 | 431,000 | 286,000 |
| Inventories | 185,000 | 199,000 | 197,000 | 193,000 | 182,000 |
| Income taxes - deferred | 117,000 | 45,000 | 22,000 | 114,000 | 145,000 |
| Other current assets | 1,960,000 | 560,000 | 727,000 | 839,000 | 416,000 |
| TOTAL | $3,188,000 | $1,663,000 | $2,110,000 | $2,024,000 | $1,669,000 |
| Non-Current Assets | |||||
| PPE Net | 9,060,000 | 9,017,000 | 8,975,000 | 8,973,000 | 4,866,000 |
| Investments And Advances | 71,000 | 79,000 | 96,000 | 86,000 | 0 |
| Intangibles | 919,000 | 935,000 | 853,000 | 927,000 | 332,000 |
| Other Non-Current Assets | 1,585,000 | 1,527,000 | 1,370,000 | 1,314,000 | 340,000 |
| TOTAL | $11,635,000 | $11,558,000 | $11,294,000 | $11,300,000 | $5,538,000 |
| Total Assets | $14,823,000 | $13,221,000 | $13,404,000 | $13,324,000 | $7,207,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 298,000 | 292,000 | 307,000 | 330,000 | 172,000 |
| Accrued Expenses | 281,000 | 257,000 | 382,000 | 312,000 | 227,000 |
| TOTAL | $2,660,000 | $999,000 | $1,246,000 | $1,130,000 | $802,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,989,000 | 5,939,000 | 5,891,000 | 6,140,000 | 3,187,000 |
| Other Non-Current Liabilities | 602,000 | 527,000 | 627,000 | 627,000 | 485,000 |
| TOTAL | $7,813,000 | $7,716,000 | $7,605,000 | $7,872,000 | $4,188,000 |
| Total Liabilities | $10,473,000 | $8,715,000 | $8,851,000 | $9,002,000 | $4,990,000 |
| Shareholders' Equity | |||||
| Common Shares | 8,000 | 8,000 | 8,000 | 8,000 | 4,374,000 |
| Retained earnings | -2,016,000 | -1,864,000 | -1,818,000 | -2,038,000 | -2,114,000 |
| Other shareholders' equity | -39,000 | -30,000 | -23,000 | -26,000 | -14,000 |
| TOTAL | $4,350,000 | $4,506,000 | $4,553,000 | $4,322,000 | $2,217,000 |
| Total Liabilities And Equity | $14,823,000 | $13,221,000 | $13,404,000 | $13,324,000 | $7,207,000 |